Search Results - "Parrinello, Nunziatina L"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells by Tibullo, Daniele, Di Rosa, Michelino, Giallongo, Cesarina, La Cava, Piera, Parrinello, Nunziatina L, Romano, Alessandra, Conticello, Concetta, Brundo, Maria V, Saccone, Salvatore, Malaguarnera, Lucia, Di Raimondo, Francesco

    Published in Frontiers in pharmacology (14-10-2015)
    “…Osteolytic bone disease is a common manifestation of multiple myeloma (MM) that leads to progressive skeleton destruction and is the most severe cause of…”
    Get full text
    Journal Article
  7. 7

    Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells by Vetro, Calogero, Romano, Alessandra, Ancora, Flavia, Coppolino, Francesco, Brundo, Maria V, Raccuia, Salvatore A, Puglisi, Fabrizio, Tibullo, Daniele, La Cava, Piera, Giallongo, Cesarina, Parrinello, Nunziatina L

    Published in Frontiers in oncology (21-05-2015)
    “…The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma by Romano, Alessandra, Parrinello, Nunziatina L., Chiarenza, Annalisa, Motta, Giovanna, Tibullo, Daniele, Giallongo, Cesarina, La Cava, Piera, Camiolo, Giuseppina, Puglisi, Fabrizio, Palumbo, Giuseppe A., Di Raimondo, Francesco

    Published in British journal of haematology (01-05-2019)
    “…Summary Hodgkin Lymphoma (HL) is associated with deep microenvironment re‐shaping and myeloid dysfunction. Given that only limited data are available regarding…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Plasmocytosis and Immunoparesis but Not Neutrophil to Lymphocyte Ratio Can Predict Time to Treatment in Smoldering Myeloma by Romano, Alessandra, Consoli, Marzia L, Parisi, Marina, Cavalli, Maide, Parrinello, Nunziatina L, Conticello, Concetta, Di Raimondo, Francesco

    Published in Blood (03-12-2015)
    “…Objectives: We recently identified the ratio between absolute neutrophils count and absolute lymphocyte count, NLR ≥2, as a predictor of progression free…”
    Get full text
    Journal Article
  13. 13

    Contribution of High-Density Neutrophils to Multiple Myeloma Microenvironment Dysregulation by Romano, Alessandra, Giallongo, Cesarina, Parrinello, Nunziatina L, Tibullo, Daniele, Puglisi, Fabrizio, Camiolo, Giusy, La Cava, Piera, Parisi, Marina, Consoli, maria Letizia, Conticello, Concetta, Di Raimondo, Francesco, Luca, Vanella

    Published in Blood (02-12-2016)
    “…Background and objective: Multiple Myeloma (MM) is a plasma cell malignancy with a well documented immune dysfunction. Previous reports in murine models and…”
    Get full text
    Journal Article
  14. 14

    Mesenchymal STEM CELLS Favor Tumor Growth By Generating Granulocyte-like Myeloid Derived Suppressor CELLS in CML Patients by Giallongo, Cesarina, Parrinello, Nunziatina L, Tibullo, Daniele, Bellofiore, Claudia, La Cava, Piera, Romano, Alessandra, Chiarenza, Annalisa, Stagno, Fabio, Vigneri, Paolo, Palumbo, Giuseppe A., Di Raimondo, Francesco

    Published in Blood (03-12-2015)
    “…INTRODUCTION. The complex interplay between cancer cells and immune system allows neoplastic cells to evade immune surveillance and expand. Recently, our and…”
    Get full text
    Journal Article
  15. 15

    Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib by Giallongo, Cesarina, Parrinello, Nunziatina L, Tibullo, Daniele, La Cava, Piera, Romano, Alessandra, Chiarenza, Annalisa, Stagno, Fabio, Vigneri, Paolo, Palumbo, Giuseppe A, Di Raimondo, Francesco, Bellofiore, Claudia

    Published in Blood (03-12-2015)
    “…INTRODUCTION. Myeloid suppressor cells are a heterogeneous group of myeloid cells that are increased in most cancer patients. Recently, we and another group…”
    Get full text
    Journal Article
  16. 16
  17. 17